Brief: Mesoblast Says Q1 Net Revenues Up 44%
29/10/2026 01:17
BRIEF-Mesoblast Says Q1 Net Revenues Up 44% Oct 29 (Reuters) - Mesoblast Limited MSB.AX:
Q1 NET REVENUES UP 44%, NET OPERATIONAL CASH SPEND IMPROVED 86% VERSUS PRIOR YEAR
CASH AT SEPT 30, 2026 US$99 MILLION; Q1 OPERATING CASH SPEND US$2.1 MILLION
Further company coverage: MSB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mesoblast
See all newsBrief: Mesoblast William Burns To Retire From Board At 2026 AGM
Brief: Mesoblast Says Q1 Net Revenues Up 44%
Australia's Mesoblast hits one-month high on upbeat quarterly update
Australia's Mesoblast drops as Bell Potter cuts target price after key drug misses sales view
Brief: Mesoblast Says FDA Approves New Potency Assay For Commercial Ryoncil